Clinical Trials · NCT06395753
A Dose Finding Study of Debio 4228 in Participants With Advanced Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Debiopharm International SA
- Enrollment
- 55
- Start date
- May 2024
- Locations
- 22 sites, 3 countries
- Primary endpoint
- Maximum Plasma Concentration (Cmax) of Debio 4228